Clinical trial
Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia
NCT00099528 · Renovis, Industry · Unknown status
Key facts
| NCT number | NCT00099528 |
|---|---|
| Title | Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia |
| Official title | REN-1654 in Post-Herpetic Neuralgia: a Multi-Center, Placebo Controlled, 3-week Dose-Finding Study, With a 3-Week Active-Treatment Extension |
| Lead sponsor | Renovis, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuralgia, Shingles, Peripheral Nervous System Disease |
| Intervention type | Drug |
| Interventions | REN-1654 |
| Enrollment | 90 |
| Start date | Aug 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Dec 16, 2004 |
| Last update posted | Jul 29, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: